Dry Eye Syndrome Treatment MarketSize and Trends

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa

Global dry eye syndrome market is estimated to be valued at US$ 7,245.3 million in 2022 and is expected to exhibit a CAGR of 16.4% during the forecast period (2022-2030).

Figure 1.Global Dry Eye Syndrome Treatment Market Share (%), by Product Type, 2022

Global Dry Eye Syndrome Treatment Market - Drivers

Increasing organic strategies such as the U.S. Food and Drug Administration approval is expected to propel growth of the global dry eye syndrome treatment market during the forecast period. For instance, in October, 2022, Novaliq, a biopharmaceutical company focusing on ocular therapeutics, announce the approval of New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for CyclASol (cyclosporine ophthalmic solution), an anti-inflammatory product for the treatment for the signs and symptoms of dry eye disease (DED).

Furthermore, key companies focusing on product launch of dry eye syndrome treatment are expected to propel growth of the global dry eye syndrome treatment market during the forecast period. For instance, in January 2022, Sun Pharmaceutical Industries, Inc., one of the global specialty generic pharmaceutical company, announced the launch of CEQUA (cyclosporine ophthalmic solution 0.09% w/v), a calcineurin inhibitor immunomodulator indicated to increase tear production in patients with moderate to severe keratoconjunctivitissicca (dry eye).

Geographies covered:
North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa